SCHEMBL536245

SCHEMBL536245

COCc1cc(C(=O)OC)ccc1-c1ccccc1C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.49
PDK2 Q15119 3/20 0.49
NOTUM Q6P988 1/20 0.49
RBP4 P02753 1/20 0.43
KIF11 P52732 3/20 0.43
MRGPRX4 Q96LA9 2/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
PDE7A Q13946 1/20 0.40
PDE3A Q14432 1/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
P4HB P07237 1/20 0.40
KDM4E B2RXH2 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10035258 0.89 PDK2 (0.46) TRPA1PDK2NOTUMRBP4KIF11
SCHEMBL407578 0.89 TRPA1 (0.50) TRPA1MRGPRX4MAOAMAOBAKR1C3
SCHEMBL10035257 0.88 NOTUM (0.52) PDK2NOTUMRBP4KIF11MRGPRX4
SCHEMBL407699 0.83 NPC1 (0.47) PDK2MRGPRX4KDM4ETSHRSMN1; SMN2
SCHEMBL536257 0.83 NOTUM (0.55) PDK2NOTUMRBP4AKR1C3AKR1C2
SCHEMBL410064 0.83 PDK2 (0.45) PDK2KIF11TSHRHSD17B10SMN1; SMN2
SCHEMBL1725700 0.82 S1PR1 (0.45) TRPA1PDK2NOTUMMAOAMAOB
SCHEMBL536675 0.82 NOTUM (0.51) PDK2NOTUMRBP4KIF11MRGPRX4
SCHEMBL319975 0.82 S1PR1 (0.46) PDK2TSHRTDP1
SCHEMBL2776641 0.82 NOTUM (0.54) TRPA1PDK2NOTUMRBP4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2414342-B1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2017-05-31 EP disclosed
US-8802704-B2 Oxadiazole derivatives MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-20120035226-A1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2012-02-09 US disclosed
EP-2414342-A1 OXADIAZOLE DERIVATIVES Merck Serono S.A. (CH) 2012-02-08 EP disclosed
WO-2010112461-A1 OXADIAZOLE DERIVATIVES MERCK SERONO S.A. (CH) 2010-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035226-A1 OXADIAZOLE DERIVATIVES OXA1L, HLA-DRB1, SSB TRPA1 2937/4885PDK2 404/4885NOTUM 3234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.